Home » Merck Receives CHMP Positive Opinion for Fertility Treatment
Merck Receives CHMP Positive Opinion for Fertility Treatment
Merck & Co. Inc. announced the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency has recommended approval of
ELONVA, or corifollitropin alfa injection, as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May